Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suraxavir Marboxil in Pediatric Uncomplicated Influenza
NCT07113392Phase 3Not yet recruiting
- Sponsor
- Jiangxi Kerui Pharmaceutical Co., Ltd.
- Start
- Aug 2025
- Primary completion
- Aug 2026
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of suraxavir marboxil in influenza, sponsored by Jiangxi Kerui Pharmaceutical Co., Ltd.. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
suraxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on NCT07113392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07113392.